A cyclin is a protein whose concentration rises and falls at specific points during cell division, acting as a timing switch that tells the cell when to move from one phase of the cycle to the next. Cyclins do this by binding to and activating partner enzymes called cyclin-dependent kinases (CDKs); without a cyclin present, those kinases sit idle. The name itself captures the defining feature: these proteins cycle up and down, accumulating steadily and then being rapidly destroyed, over and over, each time a cell divides.
How Cyclins Were First Identified
The discovery came from sea urchin eggs. In 1983, Tim Hunt and colleagues noticed that fertilized eggs of the sea urchin Arbacia punctulata produced a small group of abundant proteins that had not been detectable in unfertilized eggs. One of these proteins was destroyed every time the cells divided, then rebuilt before the next division. Eggs of a second sea urchin species and oocytes of the surf clam Spisula solidissima showed the same pattern. Hunt’s team proposed naming these oscillating proteins “cyclins.”1Cell. Cyclins: Proteins with periodic destruction at the end of cell division What made the observation so powerful was that a careful plot of cyclin levels showed the disappearance happened precisely at mitosis, the moment cells actually split. Later pulse-chase experiments confirmed that cyclin was being continuously made and then specifically chewed up at each division, not simply diluted.2Cell. The Hunt for Cyclin That build-and-destroy rhythm turned out to be the core logic the cell uses to move forward through division.
How Cyclins Activate Their Partner Kinases
A cyclin on its own does not do much biochemically. Its job is to grab hold of a CDK and switch it on. CDKs are enzymes that attach phosphate groups to other proteins, changing their behavior. But a CDK left alone is structurally locked in an inactive shape. When a cyclin binds, it forces a conformational shift that opens the CDK’s active site, allowing it to phosphorylate targets. For the classic cell-cycle CDKs, full activation typically also requires a second event: phosphorylation of the CDK itself by another kinase. This two-step process, cyclin binding plus an activating phosphorylation, gives the cell tight control.3PubMed Central. Unveiling the noncanonical activation mechanism of CDKs: insights from recent structural studies
Different cyclins appear at different times, and each one partners with a particular CDK or small set of CDKs. That pairing determines which targets get phosphorylated and therefore which cellular events get triggered. Think of it like a set of keys cut to fit specific locks: cyclin D pairs with CDK4 or CDK6 in early G1 phase, cyclin E pairs with CDK2 at the G1-to-S boundary, cyclin A pairs with CDK2 during S phase and later with CDK1, and cyclin B pairs with CDK1 to drive entry into mitosis. The sequential rise and fall of each cyclin hands the baton from one phase to the next.
Getting the Cell Committed to Divide
Before a cell copies its DNA, it must first decide whether conditions are right. That decision happens in G1, the gap phase that precedes DNA replication. Growth signals from outside the cell push production of cyclin D, which partners with CDK4 or CDK6. The resulting complex goes after a protein called Rb (the retinoblastoma protein), which normally acts as a brake on division by sitting on top of genes the cell needs for S phase. Cyclin D-CDK4/6 phosphorylates Rb, loosening its grip. In early G1, cyclin D-CDK4/6 only partially phosphorylates Rb, keeping it in a state that still allows some gene repression.4PubMed. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb
The mechanism by which cyclin D docks onto Rb is specific: the complex recognizes a particular alpha-helix at Rb’s tail end. When researchers mutated that helix, Rb could no longer be phosphorylated properly, and cells piled up in G1 arrest. In experiments, disrupting this docking interaction pushed the fraction of cells stuck in G1 from about half to roughly three-quarters and increased cell size by more than 50%, consistent with cells that keep growing but cannot divide.5Molecular Cell. Cyclin D-Cdk4,6 Drives Cell Cycle Progression through Phosphorylation of Retinoblastoma Protein by a Distinct Docking Mechanism This interaction is considered a critical driver of cell-cycle entry.6PubMed Central. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix
Crossing Into S Phase
Once cyclin D-CDK4/6 has weakened Rb enough, genes for the next cyclin become accessible. Cyclin E levels rise in late G1. Cyclin E binds CDK2, and this complex finishes the job of fully inactivating Rb by piling on more phosphate groups. When researchers measured cyclin E-CDK2 activity across the cell cycle, they found it peaked sharply in late G1 and early S phase, exactly the window when the cell commits to DNA replication.7PubMed. Association of human cyclin E with a periodic G1-S phase protein kinase Overproducing cyclin E shortened G1, while blocking it with antibodies during G1 stopped cells from entering S phase entirely.8PubMed Central. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
Beyond flipping the Rb switch, cyclin E-CDK2 also phosphorylates proteins directly involved in setting up DNA replication origins, the spots along chromosomes where copying machinery will begin. This positions the complex as both gatekeeper and activator of the S phase program.9PubMed Central. Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
Preventing Double Copying of DNA
One of the most dangerous things a cell can do is replicate the same stretch of DNA twice during a single S phase. Extra copies lead to chromosome breaks and genomic chaos. To prevent this, cyclin A-CDK2, which rises during S phase, phosphorylates a licensing factor called Cdt1. Once phosphorylated, Cdt1 gets tagged for destruction by a protein complex called SCF-Skp2. Without Cdt1, replication origins that have already fired cannot reload, so each origin fires once and only once per cycle.10Oxford Academic (Journal of Molecular Cell Biology). Prevention of DNA re-replication in eukaryotic cells This is an elegant solution: the very kinase activity that helps the cell proceed through S phase simultaneously disarms the machinery that could cause re-replication.
Entering Mitosis
The transition into mitosis, where the cell actually divides, is driven by cyclin B pairing with CDK1. This complex was originally called maturation-promoting factor (MPF) long before its molecular identity was known, because extracts containing it could force frog eggs into division.11PubMed Central. Cyclins regulating oocyte meiotic cell cycle progression Cyclin B1 accumulates in the cytoplasm throughout interphase, then abruptly moves into the nucleus just before the nuclear envelope breaks down. This redistribution is remarkably fast, taking only about three minutes in mammalian cells, and it runs on a self-reinforcing loop: nuclear cyclin B1 promotes its own phosphorylation, and that phosphorylation promotes more nuclear import, creating a switch-like, all-or-nothing commitment to mitosis.12Cell. Spatial Positive Feedback Drives the Irreversible Transition from Interphase to Mitosis
Once inside the nucleus, cyclin B-CDK1 phosphorylates hundreds of substrates: structural proteins that hold the nucleus together, chromosome-condensation factors, motor proteins that build the mitotic spindle. The wave of phosphorylation restructures the entire cell in minutes.
How Cyclins Are Destroyed
Rising levels of cyclins push the cell forward. Destroying those same cyclins is equally critical for preventing the cell from getting stuck or reverting to a previous phase. Two major protein-degradation systems handle different cyclins at different times.
Cyclin B is dismantled by the anaphase-promoting complex/cyclosome (APC/C), a large molecular machine that tags proteins with chains of ubiquitin, marking them for shredding by the proteasome. The APC/C recognizes cyclin B through a short amino-acid sequence called the destruction box, a nine-residue motif that serves as a degradation signal.13PubMed Central. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor Destroy cyclin B, and CDK1 activity drops, allowing the cell to exit mitosis, decondense its chromosomes, and rebuild the nuclear envelope.
Cyclin E, by contrast, is destroyed earlier in the cycle by a different system: the SCF complex. After cyclin E has done its job at the G1/S boundary, it gets phosphorylated, which creates a docking signal for the SCF ubiquitin ligase. Specifically, two different forms of a recognition subunit called hCdc4 work in sequence: one primes cyclin E, and the other finishes adding ubiquitin chains to trigger its destruction.14Molecular Cell. Sequential Function of hCdc4 Isoforms in Pin1-Mediated Multiubiquitylation of Cyclin E This tidy hand-off ensures cyclin E is cleared once it is no longer needed, which is important because lingering cyclin E can drive DNA damage and genomic instability.
What Happens When Things Go Wrong
The cell does not blindly follow the cyclin clock. If DNA is damaged, the cell can slam on the brakes by deploying proteins called CDK inhibitors, which physically block cyclin-CDK complexes. The best-known brake protein is p21, which is activated through both p53-dependent and p53-independent pathways in response to various forms of cellular stress.15PubMed Central. The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics When DNA damage triggers p53, p21 rises and sits on cyclin E-CDK2 (and, when needed, cyclin B-CDK1), halting progression at the G1/S boundary until the damage is repaired.16PubMed Central. p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint
Another inhibitor, p27, works alongside p21. After certain DNA-damaging events, p21 stabilizes p27 protein levels (roughly a four-fold increase in stability), and the elevated p27 selectively accumulates in CDK2 complexes rather than CDK4 complexes. Studies in ovarian tumor cells estimated that about 75% of CDK2 inhibition came from p21 and about 25% from p27, establishing a p53/p21/p27 axis as a significant component of the damage checkpoint.17PubMed Central. Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21
A second checkpoint operates later, during mitosis itself. The spindle assembly checkpoint prevents the APC/C from destroying securin and cyclin B1 until every chromosome is properly attached to the spindle apparatus.18PubMed. Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A Crucially, this checkpoint depends on CDK1 activity. Once the APC/C does destroy cyclin B1 and CDK1 activity drops, the checkpoint itself can no longer reactivate, making the transition into anaphase irreversible. If cyclin B1 were made non-degradable, cells that separate their chromosomes would paradoxically reactivate the spindle checkpoint, trapping them in a futile loop.19Current Biology. Dependency of the Spindle Assembly Checkpoint on Cdk1 Renders the Anaphase Transition Irreversible The design is elegant: the same event (cyclin B destruction) both lets the cell finish dividing and prevents the safety system from firing again after division has already started.
Cyclins and Cancer
Because cyclins are the throttle of cell division, it is no surprise that cancer often involves cyclin misregulation. Cyclin D1 is the most frequent offender. In normal cells, cyclin D1 levels respond tightly to external growth signals and fall when those signals disappear. In cancer cells, the gene encoding cyclin D1 (CCND1) is frequently amplified or overexpressed, keeping the G1 throttle open regardless of signals from the environment.20PubMed Central. Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma
In breast cancer, the consequences have been quantified. One study of invasive breast carcinomas found CCND1 gene amplification in about 19% of tumors. Patients with high amplification had a substantially increased risk of recurrence compared to those without amplification, with a hazard ratio of 2.5. High amplification was strongly associated with the Luminal B subtype, higher tumor grade, and elevated proliferation markers.21PLOS ONE. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma In estrogen-receptor-positive tumors specifically, cyclin D1 overexpression correlated with higher levels of cyclins A and B, suggesting a cascade effect where an overactive G1 cyclin pulls the entire cycle into overdrive.22PubMed Central. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
Understanding this connection has produced real drugs. Three CDK4/6 inhibitors, palbociclib, ribociclib, and abemaciclib, are now approved for treating hormone-receptor-positive, HER2-negative breast cancer. They work by blocking the kinase partners of cyclin D, effectively reinstating the G1 brake that cancer cells have disabled. All three have shown strong enough efficacy in clinical trials to become standard components of treatment regimens for this cancer subtype.23PubMed Central. Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
Cyclins Do More Than Run the Cell Cycle
The picture of cyclins as pure cell-cycle timekeepers has grown more complicated. There is now substantial evidence that cyclins and CDKs participate in processes that have nothing obvious to do with division: gene transcription, DNA repair, controlling whether a cell lives or dies, immune cell activation, and metabolic regulation.24PubMed Central. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases Cyclin D1, for instance, can directly influence gene expression by binding transcription factors independent of CDK4/6. These “moonlighting” roles mean that when researchers or drug developers target cyclins, the effects can ripple into unexpected territory. It also partly explains why cyclin D1 overexpression in cancer does more than just accelerate division; it can alter cell adhesion and invasion, two hallmarks of metastasis.
An Ancient and Conserved System
The cyclin-CDK system is not a recent evolutionary invention. Researchers studying Capsaspora owczarzaki, a single-celled organism at the boundary between unicellular life and animals, found that cyclins A, B, and E follow the same temporal order during the cell cycle as they do in human cells: cyclin E peaks around G1/S, cyclin A peaks in S phase, and cyclin B peaks at mitosis.25bioRxiv. Gradual evolution of cell cycle regulation by cyclin-dependent kinases during the transition to animal multicellularity Broader phylogenetic analyses of cyclins across animals and fungi suggest that evolutionary flexibility comes not from reinventing the cyclin-CDK handshake each time, but from reorganizing surface regions of the cyclin protein that are far from the CDK binding site, and from duplicating cyclin genes and then letting the copies diverge in function.26PubMed Central. Molecular evolution of cyclin proteins in animals and fungi
Plants use the same general logic but have expanded the cyclin family far beyond what animals carry. They must balance cell division with constant adaptation to environmental stress, and having a larger toolkit of cyclins appears to help them manage that balance. The core principle is the same, though: CDKs activated by cyclins drive passage through checkpoints, and the system is conserved across kingdoms of life.
Cyclins in Meiosis
Cell division during the production of eggs and sperm (meiosis) uses many of the same cyclins, but with distinct twists. Meiosis involves two rounds of division rather than one, and the requirements for each round differ. Cyclin A2, for example, appears dispensable for the first meiotic division in mouse oocytes, with normal spindles forming without it. But during the second meiotic division, oocytes lacking cyclin A2 show increased rates of lagging chromosomes and improper spindle-to-chromosome attachments. Cyclin A2 promotes the turnover of microtubules in the spindle, and without it, microtubule stability rises by roughly half, giving the spindle less opportunity to correct attachment errors.27Oxford Academic. Functions of cyclins and CDKs in mammalian gametogenesis Chromosome mis-segregation during meiosis is a leading cause of aneuploidy in embryos, so even subtle changes in cyclin function during this process can have outsized consequences for fertility and development.